Well, I enjoyed the "Ropren is approved BUT it needs a manufacturing licence before we can sell a single gram" announcement in July. The investment community are not fools - they know that approval means it can go on the market the next day.
Ropren is not "approved," because a single gram of Ropren is yet to be sold. If they are waiting for Bio A to rescue them, then the proverbial is soon to hit the fan in spectacular fashion.
What we need is a full and frank disclosure of the status of Ropren "approval." But instead we get a deafening silence.
- Forums
- ASX - By Stock
- SLA
- a few questions
a few questions, page-28
Featured News
Add SLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online